Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-018588
Filing Date
2022-05-18
Accepted
2022-05-18 16:09:41
Documents
1
Period of Report
2022-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4008
  Complete submission text file 0000899243-22-018588.txt   5384
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Issuer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address
DiRocco Derek (Reporting) CIK: 0001792061 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39122 | Film No.: 22939189